Authors
Latest:
5 Challenges of Increasing Online Scientific DiscussionWednesday November 9, 2022, 11am EDT | 8am PDT Discover insights and find ways to engage in the 24/7 world of online digital scientific exchange. Learn to listen to digital opinion leaders and find opportunities to engage.
Latest:
Four Critical Considerations for Launching Digital Diagnostic ToolsCreating a digital diagnostic that is supplemental and strategic to a company’s therapeutic asset requires due diligence to monetize the digital health innovation, or at least ensure optionality through the product development cycle.
Latest:
Cleared and Graded: Modernizing the 510(k) PathwayDue to increasing complexity of modern technology, FDA should consider updating its 510(k) process.
Latest:
Navigating PV Divergence: Compliance Tips for New EntrantsWith small biotechs facing similar expectations as large pharma in drug safety and pharmacovigilance, despite less resources, identifying the key differences between US and EU requirements can help these companies craft a practical path to multi-region compliance.
Latest:
COVID-19: Is the Vaccine Race Over?Cliodhna McDonough and Emily Lockey give a UK perspective on the potential pros and cons of the three leading candidates in the COVID-19 vaccine race.
Latest:
Addressing the Knowledge Gap in Biologics & Biosimilars: Is a Board Certified Biologics and Biosimilars Program the Answer?Life sciences professionals will need to keep up with market demand for biologics and biosimilars.
Latest:
Commercial Models for the Changing Life Sciences MarketLife sciences companies have an opportunity to craft a sales approach that resonates with clients, protects against future disruptions and stands out from the competition.
Latest:
Commercializing Cannabis and Patent LitigationHow the unfolding of notable infringement claim could alter commercial approaches for players in wider CBD treatment field.
Latest:
Patient Treatment & Travel: The Need for Stepped-Up SupportDesigning an effective travel and lodging patient hub program in pharma.
Latest:
The Death Knell of Pharma HCP WebsitesShould pharma brands still maintain dedicated websites to engage HCPs? Are they effective and trustworthy sources of information that offer intuitive and helpful experiences for the user?
Latest:
Where Caremark Meets Park: A New Era of Regulatory Compliance and Criminal LiabilityThe Caremark and Park doctrines require directors and managers of life sciences companies to address regulatory compliance proactively and vigorously.
Latest:
Twenty Years of GrowthLearn how Frontage Laboratories started, recent growth and expansion, and the future vision of Frontage
Latest:
Fast-Track Your Real World Data SearchNow Available On Demand! Join this webinar to learn a new way to quickly identify the right real world data sources. IQVIA Health Data Catalog makes assessing RWD fast and easy with 2000+ unique global data assets, 200+ variables describing patient data, and up-to-date profiles to efficiently compare which is most relevant for your project.
Latest:
Are We Entering the Nuclear Medicine Industrial Revolution?Achieving better outcomes for patients and advancing the fields of nuclear medicine and oncology are not just about adopting new technologies, but also about embracing a profound change in how care is delivered.
Latest:
HEOR: From Proving Product Value to Proving Its Own WorthThe recent shift in Health Economics and Outcomes Research functions across major pharmaceutical companies highlights a lack of understanding of its value.
Latest:
Three Ways Life Sciences Can Educate Stakeholders About BiosimilarsThere are several strategies life sciences companies can use to benefit from biosimilars.
Latest:
How to Build and Maintain Relationships with High-Profile ClientsFor pharma manufacturers, the primary requirement for working with high-profile clients is matching their organizational level of urgency and organization.
Latest:
Unlocking the Potential of AI in Healthcare–5 Key TakeawaysThe technology has the potential to be implemented across multiple aspects of the industry.
Latest:
The Impact of Mergers and Acquisitions on Brand in the Life Sciences IndustryLaura Child, Head of Research and Strategy at ramarketing, discusses the importance of brand reputation and the effect brand architecture associated with merger and acquisition (M&A) can have on a company’s brand.
Latest:
The Legal Environment for IVF and Other Assistive Reproductive Technology After Alabama’s Supreme Court and Legislative DecisionsUnlike for individuals or entities providing or receiving services related to in vitro fertilization (IVF), the Alabama IVF Act does not grant immunity to manufacturers, but it limits damages for their violations to the cost of an IVF cycle.
Latest:
Expert Roundup: How Technology is Shaping the Future of Life SciencesIndustry leaders share perspectives on moving the life sciences industry forward.
Latest:
The Real Value of AI in Healthcare? Strengthening the Doctor-Patient RelationshipWhy empowering both parties with the tools and data they need to make clinical decisions should be a top priority in the AI renaissance—to bolster patient care and improve health outcomes.
Latest:
Bridging the Divide: Medical's Omnichannel MomentumHow pharma medical affairs and commercial teams are synchronizing their capabilities to boost omnichannel marketing strategies and better understand customer engagement needs.
Latest:
Moving Toward the Pharmaceutical Industry of the Future with Translational MedicineGabi Hanna, MD highlights the need for an effective therapy for acute pancreatitis.
